期刊
CELL AND TISSUE RESEARCH
卷 335, 期 1, 页码 249-259出版社
SPRINGER
DOI: 10.1007/s00441-008-0682-9
关键词
Src family kinases; Inhibitors; Tumor progression; Metastasis; Inflammation
类别
资金
- NIH [U54 CA090810, P20 CA101936, T32 CA 09599]
- NATIONAL CANCER INSTITUTE [P20CA101936, R01CA065527, T32CA009599, U54CA090810, P30CA016672] Funding Source: NIH RePORTER
Src family kinases (SFKs) are signaling enzymes that have long been recognized to regulate critical cellular processes such as proliferation, survival, migration, and metastasis. Recently, considerable work has elucidated mechanisms by which SFKs regulate normal and pathologic processes in vascular biology, including endothelial cell proliferation and permeability. Further, when inappropriately activated, SFKs promote pathologic inflammatory processes and tumor metastasis, in part through their effects on the regulation of endothelial monolayer permeability. In this review, we discuss the roles of aberrantly activated SFKs in mediating endothelial permeability in the context of inflammatory states and tumor cell metastasis. We further summarize recent efforts to translate Src-specific inhibitors into therapy for systemic inflammatory conditions and numerous solid organ cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据